Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders
NCT00000597 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2013-11-26
Summary
To determine the therapeutic effects of anti-thymocyte globulin (ATG) in patients with aplastic anemia and related bone marrow failure diseases.
Conditions
- Anemia, Aplastic
- Hematologic Diseases
- Pancytopenia
- Blood Disease
Interventions
- DRUG
-
antilymphocyte serum
- DRUG
-
nandrolone
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Neal Young · Laboratory of Hematology, NHLBI
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1982-03-31
- Completion
- 1988-12-31
More Related Trials
-
TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD
NCT00185796 ·Status: COMPLETED ·Phase: PHASE2
-
Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome
NCT00806598 ·Status: COMPLETED ·Phase: PHASE2
-
Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia
NCT00005937 ·Status: COMPLETED ·Phase: PHASE2
-
Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
NCT04965597 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
NCT00899847 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders
NCT00587054 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Ablative Allo HSCT For Hematologic Malignancies or SAA
NCT00006379 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia
NCT01145976 ·Status: UNKNOWN ·Phase: PHASE3
-
Haploidentical HCT for Severe Aplastic Anemia
NCT04558736 ·Status: RECRUITING ·Phase: PHASE2
-
Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia
NCT00005898 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome
NCT00017550 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome
NCT00001839 ·Status: COMPLETED ·Phase: PHASE2
-
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
NCT01624805 ·Status: RECRUITING ·Phase: PHASE2
-
Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients With Severe Aplastic Anemia
NCT01129323 ·Status: WITHDRAWN ·Phase: NA
-
A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia
NCT05757310 ·Status: RECRUITING ·Phase: PHASE1
-
Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
NCT02828592 ·Status: RECRUITING ·Phase: PHASE2
-
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders
NCT00053989 ·Status: COMPLETED ·Phase: PHASE2
-
Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies
NCT00185640 ·Status: COMPLETED ·Phase: PHASE2
-
Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia
NCT00471848 ·Status: COMPLETED ·Phase: PHASE2
-
Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia
NCT06695741 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia
NCT00017654 ·Status: UNKNOWN ·Phase: NA
-
Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia
NCT00005935 ·Status: COMPLETED ·Phase: PHASE2
-
Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia
NCT00065260 ·Status: COMPLETED ·Phase: PHASE2
-
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
NCT03922724 ·Status: RECRUITING ·Phase: PHASE2
-
MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
NCT06412497 ·Status: RECRUITING ·Phase: PHASE2